# The Natural History of Obstructive Sleep Apnea: A Scoping Review

## TL;DR

Obstructive sleep apnea (OSA) often resolves in children but can persist into adulthood, becoming a chronic condition influenced by obesity and aging, requiring lifelong management and early intervention.

## Contribution

This review integrates pediatric and adult data to provide a life-course perspective on OSA, highlighting early intervention opportunities.

## Key findings

- Many children with OSA experience spontaneous remission, but some develop persistent disease into adulthood.
- OSA in adults is chronic and progressive, influenced by obesity, aging, and hormonal changes.
- Weight loss and CPAP therapy can reduce OSA severity, with bariatric surgery achieving remission in up to 65% of obese patients.

## Abstract

What are the main findings?
The natural history of OSA reveals that while many children experience spontaneous remission, a substantial proportion develop persistent or recurrent disease that continues into adolescence and adulthood.In adults, OSA is predominantly a chronic and progressive condition influenced by anatomical factors, obesity, aging, and hormonal changes.

The natural history of OSA reveals that while many children experience spontaneous remission, a substantial proportion develop persistent or recurrent disease that continues into adolescence and adulthood.

In adults, OSA is predominantly a chronic and progressive condition influenced by anatomical factors, obesity, aging, and hormonal changes.

What are the implications of the main findings?
Monitor children with OSA through adolescence to detect recurrence early.Reduce adult OSA risk with weight loss, CPAP adherence, and comorbidity control.Manage OSA as a lifelong condition requiring prevention and regular follow-up.

Monitor children with OSA through adolescence to detect recurrence early.

Reduce adult OSA risk with weight loss, CPAP adherence, and comorbidity control.

Manage OSA as a lifelong condition requiring prevention and regular follow-up.

Obstructive sleep apnea (OSA) is a common disorder caused by recurrent upper airway obstruction during sleep, affecting individuals across the lifespan. In children, OSA commonly results from adenotonsillar hypertrophy and may resolve spontaneously or following surgical intervention. Among adolescents and adults, OSA is more frequently associated with modifiable lifestyle factors, particularly obesity. The natural history of OSA may evolve from intermittent snoring and mild disease to moderate or severe forms if left untreated, leading to reduced health-related quality of life and overall health deterioration. Early identification of OSA, especially in mild and moderate cases, allows timely interventions to improve OSA-associated indices and may prevent progression to severe disease. Continuous positive airway pressure therapy remains the treatment of choice for adults, providing effective symptom control and reducing long-term complications, although adherence rates vary. In obese patients, sustained weight reduction represents the most effective disease-modifying strategy: a ≥5% weight loss is associated with an approximately 80% reduction in progression risk, while bariatric surgery achieves remission in up to 60–65% of cases at one year. Emerging anti-obesity pharmacotherapies have also demonstrated clinically meaningful reductions in the apnea–hypopnea index. Comorbid conditions such as hypertension, type 2 diabetes, and depression exacerbate OSA severity, impair treatment response, and complicate overall disease management. This review uniquely integrates pediatric and adult longitudinal data, treatment-modified trajectories, and emerging therapeutic approaches to provide a life-course perspective on OSA natural history, highlighting opportunities for early, phenotype-directed intervention to possibly alter disease course and long-term outcomes.